论文部分内容阅读
历时半年多的国家药品价格谈判一直受到社会各方广泛关注,最终的谈判结果也获得了各方的认可,相关药品的价格已与我国周边国家和地区趋同,乃至接近全球最低价。国家谈判价格的落地还需哪些相关政策的跟进?国家药价谈判在取得初步经验后下一步还将有哪些动作?记者就此采访了国家卫生计生委有关部门负责人及相关专家。新品种谈判将继续专利药品和独家生产药品缺乏市场竞争,价格偏高,历来是社会各界关注
The negotiation of national drug prices, which lasted more than six months, has drawn wide attention from all sectors of society. The final outcome of negotiations has also been endorsed by all parties. The prices of related medicines have converged with those in neighboring countries and even the world’s lowest. What are the relevant policies to be followed when the price of national negotiation falls? What actions will the next step be taken after the negotiation of national drug prices with the preliminary experience? The reporter interviewed the heads and relevant experts of relevant departments of the State Health and Family Planning Commission. The negotiations on new breeds will continue the lack of market competition between proprietary drugs and exclusively manufactured drugs, and the high prices have always been the focus of the community